Sangamo Nearing Fabry Gene Therapy Deal To Fund Its Pipeline

New Hemophilia Partners Also Circling

 
• By Mandy Jackson
  
Sangamo will sign a deal for its Fabry disease gene therapy imminently (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Leadership